SkinHealth Systems Inc.
SKIN Nasdaq
SEC CIK 1818093
Follow SkinHealth Systems
Weekly email: filings, results
Revenue, last quarter
$69.2M
−2.1% vs same quarter last year
Net income
−$888K
+91.9% vs same quarter last year
EPS, diluted
−$0.14
+92% vs same quarter last year
Operating cash flow
$11.3M
+16.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $300.8M | −$9.5M |
| FY24 | $334.3M | −$29.1M |
| FY23 | $398M | −$100.1M |
| FY22 | $365.9M | - |
| FY21 | $260.1M | - |
| FY20 | $119.1M | −$29.2M |
| FY19 | $166.6M | −$1.6M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 65.3% | −6.9% | −3.2% |
| FY24 | 54.5% | −20.3% | −8.7% |
| FY23 | 39% | −32.9% | −25.2% |
| FY22 | 68% | −7.1% | - |
| FY21 | 68.6% | −15.4% | - |
| FY20 | 56.4% | −14.4% | −24.5% |
| FY19 | 63.9% | 8.1% | −1% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $37.2M |
| FY24 | $15.4M |
| FY23 | $17.9M |
| FY22 | −$117.4M |
| FY21 | −$39.6M |
| FY20 | −$15.9M |
| FY19 | −$7M |
| FY18 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $0 |
| FY24 | $0 |
| FY23 | $30.2M |
| FY22 | $160M |
| FY21 | $0 |
| FY20 | $154K |
| FY19 | $0 |
| FY18 | - |
- SkinHealth Systems
- Healthcare median
Show the numbers
| Year | SkinHealth Systems | Healthcare median |
|---|---|---|
| FY25 | −3.2% | −30.6% |
| FY24 | −8.7% | −47% |
| FY23 | −25.2% | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | −24.5% | −62.2% |
| FY19 | −1% | −46.2% |
| FY18 | - | −49.6% |